Search Within

Nursing

  1. "Pediatrics, Department of"
  2. "American Association for Cancer Research"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Pediatrics, Department of (8)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. GSK Faculty (6)
  5. Sloan Kettering Institute Faculty (5)
  6. Hematologic Malignancies, Division of (4)

More Groups

People
  1. Marc Rosenblum (3)
  2. Barry Taylor (2)
  3. Craig Sauter (2)
  4. Ira Dunkel (2)
  5. Karl Jonsson (2)
  6. Katia Manova-Todorova (2)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2018 (2)
  4. 2016 (1)
  5. 2015 (1)
  6. 2011 (1)

More Years

Publications
  1. Cancer Research (4)
  2. Clinical Cancer Research (3)
  3. Cancer Discovery (1)
Publishers
  1. American Association for Cancer Research (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overcoming barriers to tumor genomic profiling through direct-to-patient outreach
    Journal Article

    Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets
    Journal Article

    Shah, U. A.; Maclachlan, K. H.; Derkach, A.; Salcedo, M.; Barnett, K.; Caple, J.; Blaslov, J.; Tran, L.; Ciardiello, A.; Burge, M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor
    Meeting Abstract

    Wang, J.; Yao, Z.; Jonsson, P.; Allen, A.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF(V600E)-mutant brain tumor
    Journal Article

    Wang, J.; Yao, Z.; Jonsson, P.; Allen, A. N.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cells for cancer immunotherapy
    Meeting Abstract

    Curran, K. J.; Silverman, L. B.; Kobos, R.; Kernan, N. A.; Margossian, S. P.; Park, J. H.; Sauter, C. S.; Szenes, V.; Wang, X. Y.; O'Reilly, R. J.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Epstein-Barr virus-specific cytotoxic T lymphocytes for treatment of rituximab-refractory Epstein-Barr virus-associated lymphoproliferative disorder
    Meeting Abstract

    Prockop, S. E.; Doubrovina, E.; Baroudy, K.; Boulad, F.; Khalaf, R.; Papadopoulos, E. B.; Sauter, C.; Szenes, V.; Suser, S.; Wasilewski, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors
    Journal Article

    Bagatell, R.; Herzog, C. E.; Trippett, T. M.; Grippo, J. F.; Cirrincione-Dall, G.; Fox, E.; Macy, M.; Bish, J.; Whitcomb, P.; Aikin, A.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer
    Journal Article

    Tan, C. T. C.; Hancock, C.; Steinherz, P.; Bacha, D. M.; Steinherz, L.; Luks, E.; Winick, N.; Meyers, P.; Mondora, A.; Dantis, E.; more...
    Cancer Research (1987)

    Fulltext@MSK | Save